Can a cheap arthritis pill prevent deadly clots after heart valve replacement?
NCT ID NCT07411768
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily low-dose anti-inflammatory drug (colchicine) can prevent blood clots from forming on replacement heart valves after a minimally invasive valve procedure (TAVR). About 116 people who have had TAVR will either receive colchicine plus standard care or standard care alone for one year. The main goal is to see if colchicine reduces valve clots detected by special CT scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-INFLAMMATORY THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, 100037, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Heart valve fix without the hospital stay? trial tests Same-Day discharge
- Can a wearable monitor prevent heart emergencies after valve replacement?
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.
- Blood test could predict clot risk after heart valve surgery
- AI-Powered ultrasound could spot hidden heart valve disease in minutes